Eupraxia Pharmaceuticals Inc. (TSX:EPRX)
Canada · Delayed Price · Currency is CAD 11.30
-0.15 (-1.31%)
Sep 24, 2026, 10:54 AM EST
Eupraxia Pharmaceuticals Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -50.21 | -38.58 | -25.5 | -28.22 | -18.49 | -18.93 |
Depreciation & Amortization | 0.36 | 0.24 | 0.17 | 0.16 | 0.15 | 0.09 |
Loss (Gain) From Sale of Assets | 0 | 0 | -0.02 | 0 | 0.01 | - |
Stock-Based Compensation | 11.43 | 8.76 | 3.22 | 1.41 | 1.43 | 2.71 |
Other Operating Activities | -4.71 | 1.74 | -1.1 | 0.55 | 0.99 | 4.72 |
Change in Accounts Receivable | -0.54 | -0.43 | -0.1 | -0.1 | 0.23 | 0.15 |
Change in Accounts Payable | 5.81 | 2.36 | -0.71 | 0.58 | 1.32 | -0.5 |
Change in Other Net Operating Assets | 0.38 | -2.64 | -5.95 | 4.88 | -0.04 | 0.05 |
Operating Cash Flow | -37.47 | -28.55 | -29.99 | -20.75 | -14.4 | -11.72 |
Operating Cash Flow Growth | - | - | - | - | - | - |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Capital Expenditures | -0.75 | -0.59 | -0.1 | -0.07 | -0.24 | -0.34 |
Sale of Property, Plant & Equipment | - | - | 0.03 | - | 0 | - |
Investment in Securities | -79.72 | - | - | - | 10.07 | -7.11 |
Other Investing Activities | - | - | - | - | - | -3.97 |
Investing Cash Flow | -80.48 | -0.59 | -0.08 | -0.07 | 9.83 | -11.42 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Short-Term Debt Issued | - | - | - | - | - | 0.08 |
Long-Term Debt Issued | - | - | - | - | - | 10.08 |
Total Debt Issued | - | - | - | - | - | 10.16 |
Long-Term Debt Repaid | - | - | -9.14 | -0.08 | -0.14 | -0.46 |
Lease Payments | - | - | - | - | -0.07 | -0.07 |
Net Debt Issued (Repaid) | - | - | -9.14 | -0.08 | -0.14 | 9.69 |
Issuance of Common Stock | 142.18 | 76.06 | 54.92 | 21.16 | 10.94 | 29.9 |
Other Financing Activities | 9.27 | - | - | - | - | - |
Financing Cash Flow | 151.45 | 76.06 | 45.78 | 21.08 | 10.8 | 39.59 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Foreign Exchange Rate Adjustments | -0.84 | 0.54 | -1.96 | 0.82 | -0.51 | -0.06 |
Net Cash Flow | 32.66 | 47.46 | 13.76 | 1.08 | 5.73 | 16.39 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -38.23 | -29.14 | -30.1 | -20.82 | -14.63 | -12.06 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Per Share | -0.72 | -0.73 | -0.89 | -0.86 | -0.76 | -0.97 |
Levered Free Cash Flow | -18.93 | -16.3 | -20.95 | -10.78 | -8.72 | -12.98 |
Unlevered Free Cash Flow | -18.93 | -16.3 | -20.35 | -10.05 | -8.11 | -12.37 |
Free Cash Flow After Leases | -38.23 | -29.14 | -30.1 | -20.82 | -14.7 | -12.13 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash Interest Paid | - | - | 0.39 | 0.6 | 0.33 | 0.46 |
Change in Working Capital | 5.65 | -0.71 | -6.76 | 5.35 | 1.51 | -0.3 |